Cargando…
PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
While now recognized as an aid to predict repeat prostate biopsy outcome, the urinary PCA3 (prostate cancer gene 3) test has also been recently advocated to predict initial biopsy results. The objective is to evaluate the performance of the PCA3 test in predicting results of initial prostate biopsie...
Autores principales: | Ruffion, Alain, Devonec, Marian, Champetier, Denis, Decaussin-Petrucci, Myriam, Rodriguez-Lafrasse, Claire, Paparel, Philippe, Perrin, Paul, Vlaeminck-Guillem, Virginie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794752/ https://www.ncbi.nlm.nih.gov/pubmed/23994838 http://dx.doi.org/10.3390/ijms140917767 |
Ejemplares similares
-
Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
por: Tallon, Lucile, et al.
Publicado: (2014) -
Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer
por: Altintas, Dogus Murat, et al.
Publicado: (2013) -
How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancer
por: Salagierski, Maciej, et al.
Publicado: (2012) -
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Maillet, Denis, et al.
Publicado: (2021) -
Measurable selectors of PCA multifunctions with applications
por: Srebrny, Marian
Publicado: (1984)